Speech-Language Pathologists in Glenburn, ND Accepting Medicare
1 Speech-Language Pathologists found. Showing 1 - 1
 Katie Ramlo, M.S. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 102 Raymond St, Glenburn, ND 58740 Phone: 701-320-2670 |
News Archive
Prasco to market and distribute authorized generic of Shionogi's PONSTEL
Prasco Laboratories, the Authorized Generics company, announced today it has signed a supply agreement with Shionogi Inc. Under the terms of the agreement, Prasco will market and distribute Mefenamic Acid Capsules, USP 250 mg, the Authorized Generic version of Ponstel®. Prasco intends to begin shipping product immediately in the U.S. under the Prasco label.
Health Canada accepts Paladin's Silenor NDS for review
Paladin Labs Inc. and Somaxon Pharmaceuticals, Inc. today announced that Paladin has filed a New Drug Submission (NDS) that has been accepted for review by Health Canada for Silenor (doxepin) for the treatment and symptomatic relief of insomnia.
Findings may yield new treatments for visual disorders
By testing formerly blind patients within weeks of sight restoration, Sinha and his colleagues found that subjects had very limited ability to distinguish an object from its background, identify overlapping objects, or even piece together the different parts of an object. The patients gradually improved over time, and the new study suggests that dynamic information - that is, input from moving objects - is critical to the brain's ability to learn to segregate objects from their backgrounds (a task known as visual integration).
Researchers assess robotic and navigation assisted pedicle screw placement in degenerative spinal surgery
The use of robotics and computer navigation in spinal surgery is rapidly expanding. Increasing numbers of hospitals and spine surgeons are adopting the technology, which aims to enhance precision, accuracy and predictability, according to Darren R. Lebl, MD, MBA, a spine surgeon at Hospital for Special Surgery.
Study finds no gender-based differences on use of anticoagulation medications in TAVR patients
A study on the impact of using different anticoagulation medications on men and women who have undergone a transcatheter aortic valve replacement (TAVR) found no difference in early vascular complications or mortality.
› Verified 7 days ago